Researchers Identify New Markers for Prostate Cancer Risk
June 2, 2006
Scientists have identified the first evidence of a direct link between chemical exposure while in the womb and prostate cancer development later in life.
June 2, 2006
Scientists have identified the first evidence of a direct link between chemical exposure while in the womb and prostate cancer development later in life.
June 2, 2006
Amateurs and pros alike are invited to start swinging for a good cause at the first UC Cancer Center/Barrett Center Golf Classic.
June 5, 2006
UC has introduced a visionary PhD program that will train tomorrow s scientists to analyze and apply the burgeoning amounts of biological data now being provided by genetic research.
June 5, 2006
Neal Weintraub, MD, has joined UC as director of the division of cardiovascular diseases and Mable S. Stonehill Chair of Cardiology
June 5, 2006
A team of military, telecommunications and surgical experts led by UC faculty are using an unmanned aircraft and sophisticated communication tools to take the next step toward making telesurgery a reality.
June 6, 2006
It's the season of warm weather and shorts, but many Americans would rather tolerate the burden of long pants than reveal their legs because of an often embarrassing condition.
June 7, 2006
Students graduating from the University of Cincinnati (UC) College of Pharmacy won t be worrying about what they will do now 100 percent of PharmD graduates have accepted high-paying jobs or are heading to pharmacy practice residencies.
June 7, 2006
Hoxworth Blood Center at the University of Cincinnati Academic Health Center has issued critical appeal for donors with all blood types, especially Type O.
June 12, 2006
High blood sugar even in non-diabetic patients is associated with increased death in intensive care units, according to researchers at the Veterans Affairs Inpatient Evaluation Center located at the Cincinnati VA and the University of Cincinnati (UC).
June 12, 2006
Researchers at the University of Cincinnati and Lilly Research Laboratories have confirmed the existence of a second binding site on the estrogen receptor for the popular breast cancer drug tamoxifen.